C5AR1 and myeloid sarcoma: The generation of anaphylatoxin peptides associated with activated, proinflammatory microglia/macrophages and ongoing phagocytosis of neural and oligodendrocyte membranes suggests the C5a/C5aR1 axis may represent a treatment target to abrogate compartmentalised inflammation and cortical pathology in progressive MS.